Creative Medical Technology Holdings Profit Margin

The latest profit margin for CELZ is -201355.37% as of June 2026. That compares with -96093.48% in the prior-year period — down 109.5% year over year. That is below the sector sector average of 13.09%. Investors often review this figure alongside Creative Medical Technology Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, CELZ's profit margin moved from -96093.48% to -201355.37% — a 109.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Creative Medical Technology Holdings's valuation or profitability profile.

Against its sector companies, CELZ currently prints -201355.37% for profit margin, while the sector average sits near 13.09%. That is roughly 1538514.0% below the sector mean. Large gaps often invite a closer look at Creative Medical Technology Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Creative Medical Technology Holdings converts resources into returns. At -201355.37%, CELZ may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -96093.48% in the prior-year period — down 109.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CELZ's profit margin (-201355.37%), review year-over-year change from -96093.48%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.